SeaCrest Wealth Management’s Virtus Biotech ETF BBP Stock Holding History

SeaCrest Wealth Management’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-203	Closed	-$9K	–	637
2019 Q1	$9K	Hold	203	–	–	﹤0.01%	1551
2018 Q4	$7K	Hold	203	–	–	﹤0.01%	1580
2018 Q3	$9K	Hold	203	–	–	﹤0.01%	1674
2018 Q2	$9K	Hold	203	–	–	﹤0.01%	1641
2018 Q1	$8K	Buy	+203	New	+$8.55K	﹤0.01%	1644

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RFWA

RPg Family Wealth Advisory Burlington, Massachusetts $479M AUM 25.83% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

AWCI

Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SeaCrest Wealth Management's BBP Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Virtus Biotech ETF (BBP) in Q2 2019, closing a stake of 203 shares — an estimated $9K sold.

SeaCrest Wealth Management first reported a position in BBP in Q1 2018 and held it in 5 quarters. The position peaked at $9K in Q1 2019. 21 funds tracked by Wall St. Rank hold BBP as of Q2 2019.

SeaCrest Wealth Management reported no remaining Virtus Biotech ETF position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 203 Virtus Biotech ETF shares in Q2 2019, an estimated $9K.
SeaCrest Wealth Management first reported a position in Virtus Biotech ETF in Q1 2018 and held it in 5 quarters.
SeaCrest Wealth Management's Virtus Biotech ETF position peaked at $9K in Q1 2019.
21 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.